Duality Biotherapeutics (HKG:9606) said it was due to join the Hang Seng Index on Monday, Sept. 8, according to a Hong Kong bourse filing Sunday.
Shares of the biopharmaceutical firm gained nearly 11% in morning trade Monday.
The company's stock would also be eligible for inclusion to the southbound trading link of the Shanghai bourse's Shanghai-Hong Kong Stock Connect the same day.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.